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Summary
Niacin (nicotinic acid) can suppress lipolysis, but responses to dietary niacin have been in-
consistent in cattle. A widely used commercial feed additive, niacin is thought to reduce heat 
stress and decrease postpartum plasma nonesterified fatty acid (NEFA) concentration. Raw 
niacin has poor stability in the rumen, however, and it is estimated that only 5% is bioavailable. 
Recently, an encapsulated niacin (EN) product with an estimated 40% bioavailability became 
commercially available, but its effects on health and metabolism in transition cows have not 
been tested previously. Twenty-two Holstein cows were used in a study beginning 21 days 
before expected calving; cows were assigned to the EN treatment (24 g/day) or control group 
until 21 days postpartum. Results showed that EN decreased peak plasma NEFA and ketone 
concentrations after calving but also caused a 9 lb/day decrease in dry matter intake during the 
final 4 days before calving in multiparous cows. These results indicate that a high dose of EN 
can decrease postpartum plasma NEFA and ketones but also may decrease prepartum dry  
matter intake.
Introduction
Use of niacin in dairy cattle is widely studied; however, most results are inconclusive or con-
tradictory. Niacin is a B vitamin that is required in very small amounts to maintain cellular 
metabolism. At much higher inclusion rates, niacin also has the ability to suppress the release of 
fat stores. Degradation within the rumen likely destroys almost 95% of niacin fed to ruminants, 
making additional supplementation inefficient. A rumen-protected form of niacin (encapsu-
lated niacin; EN) became commercially available several years ago, providing a more effective 
option for dietary supplementation of niacin.
Fatty liver affects up to 50% of postpartum dairy cattle; this can be costly to producers because 
of milk production losses and secondary diseases, such as ketosis. Fatty liver occurs when cattle 
enter a negative energy balance, usually during the first 2 weeks of lactation. Lipolysis occurs 
as a response to the negative energy balance and results in the liver being overwhelmed by high 
blood concentrations of nonesterified fatty acids (NEFA). In experiments, niacin has been 
shown to have antilipolytic effects when given to cattle with induced fatty liver. Until this ex-
periment, no known studies have been done to explore the metabolic and production responses 
to EN in peripartum dairy cows. The purpose of this study was to determine if 24 g/day of 
dietary EN could reduce lipolysis enough to control plasma NEFA in postpartum dairy cattle. 
Other metabolic and production responses measured were body condition score, milk produc-
tion, liver composition, and dry matter intake.
Experimental Procedures
Primiparous (n = 9) and multiparous (n = 13) Holstein cows were assigned randomly within 
parity to receive either 24 g/day EN or none (control) beginning 21 days before expected calv-
ing date and continuing until 21 days postpartum. Dry matter intake and milk production were 
measured daily until day 21 postpartum. Throughout the study, liver biopsies were collected for 
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triglyceride (TG) analysis and blood samples were collected for NEFA and β-hydroxybutyrate 
(BHBA) analyses. Cattle were housed in a tie-stall facility, milked thrice daily (0400, 1100, 
and 2100 hours), and fed twice daily (0700 and 1500 hours). Data were analyzed using mixed 
models with repeated measures over time.
Results and Discussion
Dry Matter Intake
There was a treatment by time by parity effect (P < 0.07, Figure 1) on prepartum dry matter 
intake caused by a 9 lb/day decrease in dry matter intake of EN-treated cows compared with 
control cows during the final 4 days before calving. There were no treatment effects on postpar-
tum feed intake.
Plasma Traits
No prepartum treatment effects were detected for any of the plasma traits measured. In con-
trast, treatment by time by parity effects were detected for NEFA (P = 0.09, Figure 2) and 
BHBA concentrations (P = 0.03, Figure 3) during the postpartum period. Plasma NEFA 
peaked at 1700 and 1300 µM for control primiparous and multiparous cows, respectively, com-
pared with 700 and 800 µM for treated primiparous and multiparous cows, respectively. Niacin 
treatment also suppressed peak BHBA concentrations in both parity groups.
Other Measures
No treatment effects were observed for liver TG concentration, body condition score, body 
weight, or milk and milk component production.
In this study, 24 g/day of EN inhibited lipolysis in postpartum cows as demonstrated by a 
decrease in postpartum NEFA and BHBA concentrations. Depression of prepartum dry matter 
intake in multiparous cows is a novel finding and is difficult to explain. However, the results of 
this study also indicate that when EN reduced dry matter intake in multiparous cows, it still 
suppressed plasma NEFA and BHBA after calving. Although significant alterations in plasma 
lipid metabolism were detected after EN treatment, this did not result in decreased liver TG 
content. Lack of changes in liver TG content likely reflects the fact that no cows suffered  
from severe fatty liver disease in this study regardless of treatment. In summary, a high dose  
of EN can decrease postpartum plasma NEFA and BHBA. Further work is needed to under-
stand the effects of niacin on prepartum dry matter intake and mechanisms involving postpar-
tum metabolism.
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Figure 1. Dry matter intake of periparturient Holstein cows with or without 24 g/day of encapsu-
lated niacin (EN) in the diet.
Dry matter intake in EN-treated multiparous cows decreased (P < 0.01) by 9 lb/day during the final 4 
days before calving.
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Figure 2. Plasma concentrations of nonesterified fatty acids (NEFA) in periparturient Holstein 
cows with or without 24 g/day of encapsulated niacin (EN) in the diet.
A treatment by time by parity interaction was detected (P = 0.09) after calving. Plasma NEFA peaked at 
1700 and 1300 µM for primiparous and multiparous control cows, respectively, compared with 700 and 
800 µM for EN-treated primiparous and multiparous cows, respectively.
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Figure 3. Plasma concentrations of β-hydroxybutyrate (BHBA) in periparturient Holstein cows 
with or without 24 g/day of encapsulated niacin (EN) in the diet.
A treatment by time by parity interaction was detected (P = 0.02) after calving. Plasma NEFA peaked 
at 1800 and 1200 µM for primiparous and multiparous control cows, respectively, compared with 1200 
and 900 µM for EN-treated primiparous and multiparous cows, respectively.
